Global market data

Cryptocurrencies: 6,286
Markets: 574
Marketcap: $ 1.48 T
24h Vol: $ 229.82 B
BTC Dominance: 59.66%

Altimmune, Inc. (ALT) Stock Price, Quote & News

A
Altimmune, Inc.
ALT
$15.94
7.33%

Notice: Undefined index: symbol in /home/u908330461/domains/liquidary.com/public_html/wp-content/plugins/massive-stock-widgets/includes/api.php on line 362

Notice: Undefined index: symbol in /home/u908330461/domains/liquidary.com/public_html/wp-content/plugins/massive-stock-widgets/includes/api.php on line 362

Notice: Undefined index: symbol in /home/u908330461/domains/liquidary.com/public_html/wp-content/plugins/massive-stock-widgets/includes/api.php on line 365

Notice: Undefined index: company_name in /home/u908330461/domains/liquidary.com/public_html/wp-content/plugins/massive-stock-widgets/includes/api.php on line 365

Stock Screener

Altimmune, Inc.

EQUITY

type

Healthcare

sector

25.00

#employees

910 Clopper Road
20878, Gaithersburg, MD

United States

address

Altimmune, Inc.
Status: Active
Sector: Healthcare
Industry: Biotechnology
Employees: 25
Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.
Phone240-654-1450
Websitehttp://altimmune.com
y8
ad

Altimmune, Inc.​ |

Stock Market Data
Altimmune, Inc.​

Market Data

Open

$17.26 

Close vs last close

$17.20 vs $17.20

High

$17.51

Low

$15.50

Price

$15.94

Market Cap

$592.18M

24h volume

1.47M

# shares

37.14M

24h Change

$1.26

24h Change (%)

-7.33

52W high

$35.10

52w LOW

$2.50

Dividend yield

Dividend rate

eps

-1.913

Subscribe To Our Newsletter 📬

Subscribe To Our Newsletter 📬

 

Join the Liquidary Newsletter to stay up to date on recent movements in markets, insights and educational content. We will occasionally reach out to you with original content and updates on Liquidary.

 

You have Successfully Subscribed!